Cargando…
Humoral immune responses in hospitalized COVID-19 patients
BACKGROUND: The emerging coronavirus 2019 (COVID-19) disease, caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a worldwide public health crisis. Antibody analysis is an important procedure for the diagnosis of COVID-19 patients. We investigated the IgG, IgM,...
Autor principal: | Mahallawi, Waleed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072517/ https://www.ncbi.nlm.nih.gov/pubmed/33935561 http://dx.doi.org/10.1016/j.sjbs.2021.04.032 |
Ejemplares similares
-
Durability of the humoral immune response in recovered COVID-19 patients
por: Mahallawi, Waleed, et al.
Publicado: (2021) -
Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023) -
Prolonged humoral and cellular immunity in COVID-19-recovered patients()
por: Alsayb, May A., et al.
Publicado: (2021) -
In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins
por: Mahallawi, Waleed H., et al.
Publicado: (2021) -
Assessment of the influenza vaccine (VAXIGRIP) in triggering a humoural immune response
por: Mahallawi, Waleed H.
Publicado: (2017)